TABLE 1

Evidence table: histopathology, type of surgery and survival data in 21 patients who underwent cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC)

Patient numberYear [ref.]SexAge yearsType of tumourApproachType of surgerySurvival months
12013 [8]AdenocarcinomaRight thoracotomyPleurectomy8 (deceased)
2AdenocarcinomaRight thoracotomyPleurectomy/decortication1 (deceased)
3AdenocarcinomaRight VATSPleurectomy/decortication27 (deceased)
4AdenocarcinomaLeft thoracotomyPleurectomy/decortication3 (deceased)
5AdenocarcinomaRight thoracotomyPleurectomy/decortication16 (deceased)
6Adeno-squamousLeft thoracotomyPleurectomy/decortication30 (alive)
7AdenocarcinomaLeft thoracotomyPleurectomy/decortication22 (alive)
8AdenocarcinomaRight thoracotomyWedge upper lobectomy+
pleurectomy/decortication
18 (alive)
9AdenocarcinomaLeft thoracotomyPneumonectomy+pleurectomy18 (alive)
10AdenocarcinomaRight thoracotomyLower lobectomy+
pleurectomy/decortication
8 (alive)
11AdenocarcinomaLeft thoracotomyPleurectomy/decortication7 (alive)
122003 [9]Male55AdenocarcinomaThoracotomyHITHOC (first)+
panpleuropneumonectomy
32 (alive)
13Female65AdenocarcinomaThoracotomyHITHOC+
panpleuropneumonectomy
24 (alive)
14Male67Adeno-squamousThoracotomyHITHOC+
panpleuropneumonectomy
8 (deceased)
15Male50AdenocarcinomaThoracotomyHITHOC+
panpleuropneumonectomy
18 (alive)
16Female55AdenocarcinomaThoracotomyHITHOC+
panpleuropneumonectomy
12 (alive)
172003 [10]Male42AdenocarcinomaThoracotomyPleurectomy74 (deceased)
18Male49AdenocarcinomaThoracotomyPleurectomy20 (deceased)
19Male65AdenocarcinomaThoracotomyWedge+pleurectomy6 (deceased)
202015 [3]#Female53AdenocarcinomaRight VATSWedge upper lobectomy+
pleurectomy/decortication
36 (deceased)
21Male54AdenocarcinomaRight thoracotomyWedge upper lobectomy+
chest wall resection+
pleurectomy/decortication
7 (deceased)

VATS: video-assisted thoracoscopic surgery. #: our experience updated from [7].